Kaifeng Jin

School of Basic Medical Sciences

H指数:15

被引数:1,132

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TP53 mutation-biased CD8+ T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma

TP53突变偏倚的CD8+ T细胞耗竭驱动尿路上皮癌的致命结局和疗法抵抗

British Journal of Cancer

IF6.8

2026-07-110

PRE

Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinoma

自然杀伤细胞浸润在尿路上皮癌中引发性别依赖性的双相临床结局。

CANCER

IF5.1

2025-12-150

PRE

Clinicopathological and molecular correlates of clinical benefit from disitamab vedotin (RC48), a HER-2-targeting antibody-drug conjugate, in metastatic urothelial carcinoma: a multi-center, real-world study

临床病理及分子学相关指标与disitamab vedotin（RC48，一种靶向HER-2的抗体偶联药物）在转移性尿路上皮癌中临床获益的关系：一项多中心、真实世界研究

BMC Cancer

IF3.4

2025-10-030

OAAI

RAD51 Expression as a Biomarker to Predict Efficacy of Platinum-Based Chemotherapy and PD-L1 Blockade for Muscle-Invasive Bladder Cancer

JOURNAL OF IMMUNOTHERAPY

IF2.9

2024-05-270

PRE

CD103+CD8+ TISSUE-RESIDENT MEMORY T CELLS INFILTRATION PREDICTS CLINICAL OUTCOME AND ADJUVANT THERAPEUTIC BENEFIT IN MUSCLE-INVASIVE BLADDER CANCER

JOURNAL OF UROLOGY

IF6.8

2024-05-010

PRE

TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinoma

JOURNAL OF PATHOLOGY

IF5.2

2024-02-212

Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer

BRITISH JOURNAL OF CANCER

IF6.8

2024-01-112

Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer

BMC CANCER

IF3.4

2023-07-143

OAAI

Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients

BRITISH JOURNAL OF CANCER

IF6.8

2022-08-233

B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2022-08-0111

PRE

Electrochemical Biosensor Based on Chitosan- and Thioctic-Acid-Modified Nanoporous Gold Co-Immobilization Enzyme for Glycerol Determination

CHEMOSENSORS

IF3.7

2022-07-027

NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-05-0515

OAAI

Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-03-2551

OAAI

CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer

BRITISH JOURNAL OF CANCER

IF6.8

2022-02-1422

ASO Visual Abstract: Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-01-240

TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer

BRITISH JOURNAL OF CANCER

IF6.8

2022-01-1712

Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-01-095

PRE

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+T cells enriched gastric cancer patients

富含CXCL13 CD8 T细胞的胃癌患者的不良临床结局和免疫逃避环境

ONCOIMMUNOLOGY

IF6.3

2021-04-2724

OAAI

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response

ONCOIMMUNOLOGY

IF6.3

2020-12-1510

Intratumoral CD103+CD4+ T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients

ONCOIMMUNOLOGY

IF6.3

2020-11-2211

OAAI

Kaifeng Jin

个人简介

教育背景

工作经历

荣誉奖项

研究方向